$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

$mrvi Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000182323924000118 Filed on November 12, 2024

Income Statement

Concept	2024 Q3
Revenue	$65.20M
YoY Change	-2.49%
Cost Of Revenue	$36.83M
YoY Change	0.38%
Gross Profit	$28.37M
YoY Change	-5.98%
Gross Profit Margin	43.52%
Selling, General & Admin	$39.09M
YoY Change	0.57%
% of Gross Profit	137.76%
Research & Development	$4.344M
YoY Change	-0.07%
% of Gross Profit	15.31%
Depreciation & Amortization	$5.044M
YoY Change	23.9%
% of Gross Profit	17.78%
Operating Expenses	$43.43M
YoY Change	0.51%
Operating Profit	-$169.1M
YoY Change	996.93%
Interest Expense	$13.63M
YoY Change	17.16%
% of Operating Profit
Other Income/Expense, Net	$72.00K
YoY Change	9.09%
Pretax Income	-$175.6M
YoY Change	754.17%
Income Tax	$311.0K
% Of Pretax Income
Net Earnings	-$99.04M
YoY Change	1432.62%
Net Earnings / Revenue	-151.9%
Basic Earnings Per Share	-$0.70
Diluted Earnings Per Share	-$0.70
COMMON SHARES
Basic Shares Outstanding	141.6M shares
Diluted Shares Outstanding	141.6M shares

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$578.2M
YoY Change	-0.25%
Cash & Equivalents	$578.2M
Short-Term Investments
Other Short-Term Assets	$21.66M
YoY Change	-5.42%
Inventory	$50.41M
Prepaid Expenses
Receivables	$28.87M
Other Receivables	$0.00
Total Short-Term Assets	$679.1M
YoY Change	-3.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.6M
YoY Change	-23.96%
Goodwill	$171.8M
YoY Change	-47.31%
Intangibles	$201.9M
YoY Change	-11.41%
Long-Term Investments
YoY Change
Other Assets	$60.91M
YoY Change	-28.82%
Total Long-Term Assets	$599.1M
YoY Change	-61.76%
TOTAL ASSETS
Total Short-Term Assets	$679.1M
Total Long-Term Assets	$599.1M
Total Assets	$1.278B
YoY Change	-43.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.494M
YoY Change	1.0%
Accrued Expenses	$38.50M
YoY Change	-31.31%
Deferred Revenue	$1.834M
YoY Change	-28.16%
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$5.440M
YoY Change	0.0%
Total Short-Term Liabilities	$63.24M
YoY Change	-19.18%
LONG-TERM LIABILITIES
Long-Term Debt	$516.3M
YoY Change	-0.62%
Other Long-Term Liabilities	$54.24M
YoY Change	-15.95%
Total Long-Term Liabilities	$570.5M
YoY Change	-2.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$63.24M
Total Long-Term Liabilities	$570.5M
Total Liabilities	$665.1M
YoY Change	-51.64%
SHAREHOLDERS EQUITY
Retained Earnings	$167.0M
YoY Change	-57.36%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$345.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.278B
YoY Change	-43.63%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	-$99.04M
YoY Change	1432.62%
Depreciation, Depletion And Amortization	$5.044M
YoY Change	23.9%
Cash From Operating Activities	$13.14M
YoY Change	-6.84%
INVESTING ACTIVITIES
Capital Expenditures	$9.591M
YoY Change	-39.68%
Acquisitions
YoY Change
Other Investing Activities	$632.0K
YoY Change	110.67%
Cash From Investing Activities	-$8.959M
YoY Change	-42.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	809.0K
YoY Change	15.57%
NET CHANGE
Cash From Operating Activities	13.14M
Cash From Investing Activities	-8.959M
Cash From Financing Activities	809.0K
Net Change In Cash	4.986M
YoY Change	-812.29%
FREE CASH FLOW
Cash From Operating Activities	$13.14M
Capital Expenditures	$9.591M
Free Cash Flow	$3.545M
YoY Change	-296.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001823239
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Registrant Name EntityRegistrantName	Maravai LifeSciences Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2786970
	dei	Entity Address Address Line1 EntityAddressAddressLine1	10770 Wateridge Circle
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	City Area Code CityAreaCode	858
	dei	Local Phone Number LocalPhoneNumber	546-0004
	dei	Security12b Title Security12bTitle	Class A common stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	MRVI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	578157000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	574962000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28873000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54605000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	50409000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	51397000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	234314000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	82282000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-169114000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15417000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7071000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7432000	usd
	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	39000	usd
	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	2342000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2384000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1386000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-214980000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38450000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1853000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10057000	usd
	us-gaap	Profit Loss ProfitLoss	-213127000	usd
	us-gaap	Profit Loss ProfitLoss	-28393000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-206000	usd
	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25246000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	579605000	usd
	mrvi	Accrued Receivable For Capital Expenditures To Be Reimbursed Under Government Contract AccruedReceivableForCapitalExpendituresToBeReimbursedUnderGovernmentContract	3528000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3931000	usd
	mrvi	Noncash Business Combination Contingent Consideration Arrangements Liability NoncashBusinessCombinationContingentConsiderationArrangementsLiability	5289000	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21659000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18948000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-15323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-118701000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13070000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131930000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136595000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131845000	shares
	us-gaap	Profit Loss ProfitLoss	-213127000	usd
	us-gaap	Profit Loss ProfitLoss	-28393000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-15323000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-118701000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13070000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-242000	usd
CY2023Q3	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9987000	usd
	us-gaap	Profit Loss ProfitLoss	-28393000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892281000	usd
	us-gaap	Profit Loss ProfitLoss	-213127000	usd
	us-gaap	Profit Loss ProfitLoss	-28393000	usd
	us-gaap	Depreciation Depreciation	15386000	usd
	us-gaap	Depreciation Depreciation	8966000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20629000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20487000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6324000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6348000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2238000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2186000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	38870000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	25246000	usd
	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-39000	usd
	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-2342000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1478000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4474000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25704000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-93180000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-50000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2833000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-970000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1761000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1531000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-21118000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1526000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-558000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-5149000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-14338000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22103000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	118434000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	69622000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23809000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48754000	usd
	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	5424000	usd
	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	8969000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19385000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-109407000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	578157000	usd
	mrvi	Accrued Receivable For Capital Expenditures To Be Reimbursed Under Government Contract AccruedReceivableForCapitalExpendituresToBeReimbursedUnderGovernmentContract	1410000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	32862000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1287000	usd
	mrvi	Noncash Business Combination Contingent Consideration Arrangements Liability NoncashBusinessCombinationContingentConsiderationArrangementsLiability	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	500000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141555000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141555000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131930000	shares
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-8640000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-94426000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99038000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6462000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	776414000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202779000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	214804000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	36826000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	36686000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	-1220000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Costs And Expenses CostsAndExpenses	400266000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	239302000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-197487000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	13634000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	11637000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	36437000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	30492000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	21367000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	20268000	usd
CY2024Q3	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	39000	usd
CY2023Q3	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	1007000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	72000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	66000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-175644000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20563000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	311000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5461000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-175955000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-15102000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-76917000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8640000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-94426000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-99038000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6462000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-175955000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-15102000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-76917000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518707000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	31327000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	31897000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54237000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	59494000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	665088000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	697566000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	175581000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	128503000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	167036000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	285737000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	345140000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	416753000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	267987000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	373131000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	613127000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	789884000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1278215000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1487450000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	679098000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	699912000	usd
CY2024Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	164555000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	162900000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	171790000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	326029000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	201858000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	220987000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60914000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77622000	usd
CY2024Q3	us-gaap	Assets Assets	1278215000	usd
CY2023Q4	us-gaap	Assets Assets	1487450000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38498000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60237000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1834000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3360000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	750000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	633000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	63241000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87468000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	516283000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65200000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66865000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	113432000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	113635000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39087000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38864000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	120528000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	112912000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4344000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4347000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14660000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12686000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-178000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2385000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1373000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	69000	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154239000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154239000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	us-gaap	Restructuring Charges RestructuringCharges	-4000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24498000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	136595000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131845000	shares
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-382000	usd
CY2024Q3	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13050000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-175955000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	613127000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	789884000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-1928000	usd
	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38870000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	572000	usd
	us-gaap	Profit Loss ProfitLoss	-213127000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	613127000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	897638000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-15102000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892281000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905243000	usd
	mrvi	Effects Of Organizational Transactions Value EffectsOfOrganizationalTransactionsValue	-2000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9607000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9808000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1373000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	69000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154239000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3625000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8962000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	572000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	9607000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4080000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4080000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	453000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	190000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	7062000	usd
	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	3845000	usd
	mrvi	Payment Of Acquisition Contingent Consideration Holdback PaymentOfAcquisitionContingentConsiderationHoldback	0	usd
	mrvi	Payment Of Acquisition Contingent Consideration Holdback PaymentOfAcquisitionContingentConsiderationHoldback	9706000	usd
	mrvi	Share Based Payment Arrangement Value Shares Withheld For Tax Withholding Obligation ShareBasedPaymentArrangementValueSharesWithheldForTaxWithholdingObligation	-1480000	usd
	mrvi	Share Based Payment Arrangement Value Shares Withheld For Tax Withholding Obligation ShareBasedPaymentArrangementValueSharesWithheldForTaxWithholdingObligation	331000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	477000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-61560000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3195000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52533000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	574962000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	632138000	usd
	us-gaap	Interest Paid Net InterestPaidNet	35866000	usd
	us-gaap	Interest Paid Net InterestPaidNet	32188000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	644000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3077000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1805000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3703000	usd
	mrvi	Noncash Purchase Of Patented Technology NoncashPurchaseOfPatentedTechnology	500000	usd
	mrvi	Noncash Purchase Of Patented Technology NoncashPurchaseOfPatentedTechnology	0	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires the Company to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenue and expenses, and related disclosures. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates and judgments on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions the Company may undertake in the future. Significant estimates include, but are not limited to, the measurement of right-of-use assets and lease liabilities and related </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incremental borrowing rate, the payable to related parties pursuant to the Tax Receivable Agreement (as defined in Note 11), the realizability of our net deferred tax assets, and the valuation of goodwill and intangible assets. Actual results could differ materially from those estimates.</span></div>
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2900000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5500000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202779000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66865000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	214804000	usd
	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	800000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1400000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	700000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154200000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains the majority of its cash balances at multiple financial institutions that </span></div>management believes are of high-credit-quality and financially stable. Cash is deposited with major financial institutions in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash is held. The Company provides credit, in the normal course of business, to international and domestic distributors as well as certain customers, which are geographically dispersed. The Company attempts to limit its credit risk by performing ongoing credit evaluations of its customers and maintaining adequate allowances for potential credit losses.
CY2023Q4	us-gaap	Goodwill Goodwill	326029000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154239000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	171790000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
CY2024Q3	us-gaap	Number Of Reporting Units NumberOfReportingUnits	4	reporting_unit
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154200000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	351262000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	149404000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	201858000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y1M6D
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	349762000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	128775000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	220987000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y8M12D
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6901000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	27460000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	27223000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	26207000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	25987000	usd
CY2024Q3	mrvi	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	88080000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	201858000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1400000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2003000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1373000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	630000	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16665000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19338000	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10748000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12680000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	22996000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19379000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	50409000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	51397000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14828000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12905000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	9004000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	9202000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7275000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6780000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2269000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2277000	usd
CY2024Q3	mrvi	Accrued Property And Equipment Current AccruedPropertyAndEquipmentCurrent	1124000	usd
CY2023Q4	mrvi	Accrued Property And Equipment Current AccruedPropertyAndEquipmentCurrent	632000	usd
CY2024Q3	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	1038000	usd
CY2023Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	2156000	usd
CY2024Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	779000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1001000	usd
CY2024Q3	mrvi	Accrued Restructuring Costs Current AccruedRestructuringCostsCurrent	36000	usd
CY2023Q4	mrvi	Accrued Restructuring Costs Current AccruedRestructuringCostsCurrent	2814000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2145000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3024000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38498000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60237000	usd
CY2024Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	1500000	usd
	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	5000000.0	usd
CY2023Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	300000	usd
	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	2700000	usd
CY2024Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Due In Remainder Of Fiscal Year UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear	1234000	usd
CY2024Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	590000	usd
CY2024Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	390000	usd
CY2024Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	8000	usd
CY2024Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	2222000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	800000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7317000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8973000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	521723000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	524147000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	516283000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518707000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1360000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5440000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5440000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	516800000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	529040000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-175955000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-15102000	usd
	us-gaap	Profit Loss ProfitLoss	-213127000	usd
	us-gaap	Profit Loss ProfitLoss	-28393000	usd
CY2024Q3	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-76917000	usd
CY2023Q3	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-8640000	usd
	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-94426000	usd
	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-15323000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-99038000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99038000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6462000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6462000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-118701000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-118701000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13070000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13070000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	141555000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141555000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131930000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131930000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136595000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	136595000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131845000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131845000	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	116848000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	127395000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	117122000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	126835000	shares
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-175644000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20563000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-214980000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38450000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	311000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5461000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1853000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10057000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.266
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.009
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.262
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.009
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.266
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.262
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3400000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5200000	usd
	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1800000	usd
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	200000	usd
	mrvi	Assumed Effective Income Tax Rate Reconciliation Percent AssumedEffectiveIncomeTaxRateReconciliationPercent	0.467
	mrvi	Assumed Effective Income Tax Rate Reconciliation Business Income Deduction Unavailable Percent AssumedEffectiveIncomeTaxRateReconciliationBusinessIncomeDeductionUnavailablePercent	0.541
CY2024Q3	mrvi	Tax Distribution Payable TaxDistributionPayable	0	usd
	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Unpaid TaxReceivableAgreementPercentageOfTaxBenefitsUnpaid	0.15
CY2023	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2023Q1	mrvi	Weighted Average Price Period Used For Calculation WeightedAveragePricePeriodUsedForCalculation	P50D
CY2023Q1	mrvi	Noncontrolling Interest Common Unit Forfeiture Percentage NoncontrollingInterestCommonUnitForfeiturePercentage	0.037
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65200000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	66865000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202779000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	214804000	usd
CY2024Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6891000	usd
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6870000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20629000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20487000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	5044000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	4071000	usd
	us-gaap	Depreciation Depreciation	15386000	usd
	us-gaap	Depreciation Depreciation	8966000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	13634000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	11637000	usd
	us-gaap	Interest Expense InterestExpense	36437000	usd
	us-gaap	Interest Expense InterestExpense	30492000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7071000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7432000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	21367000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	20268000	usd
CY2024Q3	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	13645000	usd
CY2023Q3	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	15937000	usd
	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	43693000	usd
	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	49188000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-178000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2385000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1373000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	69000	usd
CY2024Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	919000	usd
CY2023Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3268000	usd
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4641000	usd
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	9198000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13050000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9987000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38870000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25246000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	833000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	46000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	863000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3708000	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	114000	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	0	usd
	us-gaap	Professional Fees ProfessionalFees	114000	usd
	us-gaap	Professional Fees ProfessionalFees	0	usd
CY2024Q3	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	67000	usd
CY2023Q3	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	77000	usd
	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	-2374000	usd
	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	-1370000	usd
CY2024Q3	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-39000	usd
CY2023Q3	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-1007000	usd
	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-39000	usd
	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-2342000	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154239000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	154239000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	us-gaap	Restructuring Costs RestructuringCosts	-10000	usd
CY2023Q3	us-gaap	Restructuring Costs RestructuringCosts	0	usd
	us-gaap	Restructuring Costs RestructuringCosts	1000	usd
	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2024Q3	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-946000	usd
CY2023Q3	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-701000	usd
	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-1578000	usd
	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-1615000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-175644000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20563000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-214980000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38450000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	311000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5461000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1853000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10057000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-175955000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-15102000	usd
	us-gaap	Profit Loss ProfitLoss	-213127000	usd
	us-gaap	Profit Loss ProfitLoss	-28393000	usd
CY2024Q3	mrvi	Restructuring Costs Included In Share Based Payment Arrangement Expense Benefit RestructuringCostsIncludedInShareBasedPaymentArrangementExpenseBenefit	0	usd
	mrvi	Restructuring Costs Included In Share Based Payment Arrangement Expense Benefit RestructuringCostsIncludedInShareBasedPaymentArrangementExpenseBenefit	-1200000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001823239-24-000118-index-headers.html	Edgar Link	pending
0001823239-24-000118-index.html	Edgar Link	pending
0001823239-24-000118.txt	Edgar Link	pending
0001823239-24-000118-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrvi-20240930.htm	Edgar Link	pending
mrvi-20240930.xsd	Edgar Link	pending
mrvi-q32024form10xqxex311x.htm	Edgar Link	pending
mrvi-q32024form10xqxex312x.htm	Edgar Link	pending
mrvi-q32024xform10xqxex321.htm	Edgar Link	pending
mrvi-q32024xform10xqxex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
mrvi-20240930_def.xml	Edgar Link	unprocessable
mrvi-20240930_lab.xml	Edgar Link	unprocessable
mrvi-20240930_pre.xml	Edgar Link	unprocessable
mrvi-20240930_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mrvi-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2024 Q3 Form 10-Q Financial Statement

#000182323924000118 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2024 Q3 Form 10-Q Financial Statement

#000182323924000118 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi